Influence of haematocrit on international normalised ratio (INR) differences between a whole blood point-of-care coagulation monitor and reference prothrombin time in plasma

Thrombosis and Haemostasis

Volumn 100, Issue 6, 2008, Pages 1181-1184

  Van Den Besselaar, Anton M H P ^a   Witteveen, Evelina ^a   Van Der Meer, Felix J M ^a  

^a LEIDEN UNIVERSITY MEDICAL CENTER   (Netherlands)

Author keywords

Haematocrit; International Normalized Ratio; Oral anticoagulant; Point of care testing; Prothrombin time

Indexed keywords

ANTIVITAMIN K; CALCIUM ION; CITRATE SODIUM; IRON OXIDE; THROMBOPLASTIN;

ARTICLE; BLOOD CLOTTING TIME; BLOOD SAMPLING; FIBRIN FORMATION; HEMATOCRIT; INTERNATIONAL NORMALIZED RATIO; POINT OF CARE TESTING; PRIORITY JOURNAL; PROTHROMBIN TIME; SELF EVALUATION; TEST STRIP;

ANTICOAGULANTS; BLOOD COAGULATION; DRUG MONITORING; HEMATOCRIT; HUMANS; INTERNATIONAL NORMALIZED RATIO; POINT-OF-CARE SYSTEMS; PREDICTIVE VALUE OF TESTS; PROTHROMBIN TIME; REAGENT STRIPS; REFERENCE VALUES; REPRODUCIBILITY OF RESULTS; TIME FACTORS; VITAMIN K;

EID: 57349179871     PISSN: 03406245     EISSN: None     Source Type: Journal    
DOI: 10.1160/TH08-04-0257     Document Type: Article

References (11)

1. Braun S, Watzke H, Hasenkam JM, et al. Performance evaluation of the new CoaguChek XS system compared with the established CoaguChek system by patients experienced in INR-self management. Thromb Haemost 2007; 97: 310-314.
2. Van den Besselaar AMHP, Breddin K, Lutze G, et al. Multicenter evaluation of a new capillary blood prothrombin time monitoring system. Blood Coag Fibrinol 1995; 6: 726-732.
3. WHO Expert Committee on Biological Standardization. Guidelines for thromboplastins and plasma used to control oral anticoagulant therapy. WHO Technical Report Series. Forty-eighth Report. WHO, Geneva, 1999.
4. Adcock DM, Kressin DC, Marlar RA. Effect of 3.2% vs. 3.8% sodium citrate concentration on routine coagulation testing. Am J Clin Pathol 1997; 107: 105-110.
5. Marlar RA, Potts RM, Marlar AA. Effect on routine and special coagulation testing values of citrate anticoagulant adjustment in patients with high hematocrit values. Am J Clin Pathol 2006; 126: 400-405.
6. Van den Besselaar AMHP. A comparison of INRs determined with a whole blood prothrombin time device and two international reference preparations for thromboplastin. Thromb Haemost 2000; 84: 410-412.
7. Van den Besselaar AMHP. Accuracy, precision, and quality control for point-of-care testing of oral anticoagulation. J Thromb Thrombolysis 2001; 12: 35-40.
8. Van den Besselaar AMHP. The response of Quick's prothrombin time test to oral anticoagulation. Influence of thromboplastin source and calcium chloride concentration. Arch Pathol Lab Med 1994; 118: 145-149.
9. Meijer P, Kluft C, Poller L, et al. A national field study of quality assessment of CoaguChek point-of-care testing prothrombin time monitors. Am J Clin Pathol 2006; 126: 756-761.
10. Poller L, Keown M, Chauhan N, et al. Reliability of international normalised ratios from two point of care test systems: comparison with conventional methods. Br Med J 2003; 327: 30.
11. Clinical and Laboratory Standards Institute. One Stage Prothrombin Time (PT) and Activated Partial Thromboplastin Time (aPTT) Test. H47-A2. Wayne, PA: Clinical and Laboratory Standards Institute; 2001.